A detailed history of Pitcairn CO transactions in Sanofi stock. As of the latest transaction made, Pitcairn CO holds 7,644 shares of SNY stock, worth $440,753. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,644
Previous 5,627 35.85%
Holding current value
$440,753
Previous $273,000 35.53%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$45.39 - $50.36 $91,551 - $101,576
2,017 Added 35.85%
7,644 $370,000
Q1 2024

May 13, 2024

BUY
$45.75 - $52.48 $257,435 - $295,304
5,627 New
5,627 $273,000
Q4 2023

Jul 09, 2024

BUY
$43.13 - $54.79 $93,721 - $119,058
2,173 Added 38.62%
7,800 $388 Million
Q3 2023

Jul 09, 2024

BUY
$50.95 - $55.2 $33,372 - $36,156
655 Added 15.95%
4,761 $255 Million
Q2 2023

Jul 09, 2024

SELL
$50.45 - $57.18 $76,734 - $86,970
-1,521 Reduced 27.03%
4,106 $221 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $145B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Pitcairn CO Portfolio

Follow Pitcairn CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.